Back to Agenda
Panel Discussion
Session Chair(s)
Yuko Kojima, RPh
Sr. Executive Director
Eli Lilly Japan K.K., Japan
Rika Abe, RPh
Research Administrator, Office of the Fugaku Society 5.0 Initiative
RIKEN Center for Computational Science, Japan
Speaker(s)
Motonori Kimura
Keio University Hospital, Japan
Takamasa Sakai
Meijo University, Japan
Assistant Professor, Drug Informatics, Faculty of Pharmacy, Meijo University
Keiko Akamatsu
Eli Lilly Japan K.K., Japan
Wataru Kuga, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer
Shinya Takemoto, MSc
Chugai Pharmaceutical Co., Ltd., Japan
Group Manager, Safety Information Strategy Group, Risk Communication Department
Hiroki Nagahama, MS
GlaxoSmithKline K.K., Japan
Director, Medical Governance and Risk Management
Hideo Nakada, RPh
Keio University, Japan
Deputy Associate Manager, Department of Hospital Pharmacy
Have an account?